Register information Patent

DE file number : 60 2016 013 242.7 (Status: pending/in force, Query started: April 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 013 242.7
96EP file numberEAKZ16 72 5997.7
86WO file numberWAKZPCT/US2016/033099
97EP publication numberEPN3298021
87WO publication numberWPN2016187316
54Designation/titleTIALVOCIDIB-PRODRUGS MIT ERHÖHTER BIOVERFÜGBARKEIT
51IPC main classICM
(ICMV)		 C07F 9/12 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/661 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATMay 18, 2016
96EP application dateEATMay 18, 2016
86WO application dateWATMay 18, 2016
43Date of first publicationOTNov 24, 2016
Date of publication of grantPETMay 1, 2019
71/73Applicant/ownerINHSumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Marlborough, MA, US
72InventorINSIDDIQUI-JAIN, Adam, South Jordan, Utah 84095, US; BEARSS, David, J., Alpine, Utah 84004, US
74RepresentativeVTRHoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE
Address for service HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562163188 P
May 18, 2015
Due dateFT
FG		May 31, 2026
Annual fee for the 11th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003298021A1
Searchable text: EP000003298021A1
Original document: EP000003298021B1
Searchable text: EP000003298021B1
Original document: WO002016187316
Searchable text: WO002016187316
43Date of first publicationEVTNov 24, 2016
Date of the first transfer into DPMAregisterEREGTMar 28, 2018
Date of the (most recent) update in DPMAregisterREGTApr 2, 2025
(Show all update days)(Hide all update days)
  • Apr 2, 2025
    • Due date: changed
  • Nov 12, 2024
    • Representative: changed
  • Jun 8, 2024; Aug 24, 2023; Jul 19, 2023; Jun 7, 2023; Jul 6, 2022; Jun 9, 2022; Jun 2, 2022; Aug 5, 2021; Jun 8, 2021; Jan 8, 2021; Dec 1, 2020; Nov 27, 2020; Jun 5, 2020; Apr 23, 2020; Mar 19, 2020; Aug 23, 2019; Aug 3, 2019; Jul 25, 2019; May 23, 2019; Apr 12, 2019; Apr 11, 2019; Mar 14, 2019
    • Historical data not available for this/these date(s)
  • Mar 28, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Nov 24, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Mar 28, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 9, 2018 May 9, 2018 Details anzeigen
4 Change of classification Change of IPC main class Sep 12, 2018  Details anzeigen
5 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) May 1, 2019  Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant May 23, 2019 May 23, 2019 Details anzeigen
7 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Feb 4, 2020 Apr 23, 2020 Details anzeigen
8 New applicant/owner details New applicant/owner details Nov 26, 2020 Jan 7, 2021 Details anzeigen
9 New applicant/owner details New applicant/owner details Jun 1, 2022 Jul 7, 2022 Details anzeigen
10 New applicant/owner details New applicant/owner details Jul 18, 2023 Aug 24, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTNov 24, 2016
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 28, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 9, 2018
Issue numberHN19
YearPJ2018
Publication dateVTMay 9, 2018
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTSep 12, 2018
51IPC main classICM
(ICMV)		 C07F 9/12 (2006.01)
51Previous IPC main classICMF
(ICMVF)		 C07F 9/12 (2006.01)
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMay 1, 2019
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMay 23, 2019
Issue numberHN21
YearPJ2019
Publication dateVTMay 23, 2019
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTFeb 4, 2020
Issue numberHN17
YearPJ2020
Publication dateVTApr 23, 2020
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 26, 2020
Issue numberHN1
YearPJ2021
Publication dateVTJan 7, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSumitomo Dainippon Pharma Oncology, Inc. (n.d.Ges.d.Staates Delaware), Cambridge, MA, US
71/73Previous applicant/ownerINHFTolero Pharmaceuticals, Inc., Lehi, Utah, US
Date of update of the procedureREGTJan 8, 2021
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 1, 2022
Issue numberHN27
YearPJ2022
Publication dateVTJul 7, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Cambridge, MA, US
71/73Previous applicant/ownerINHFSumitomo Dainippon Pharma Oncology, Inc. (n.d.Ges.d.Staates Delaware), Cambridge, MA, US
Date of update of the procedureREGTJul 6, 2022
View procedures New applicant/owner details (No.: 10)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 18, 2023
Issue numberHN34
YearPJ2023
Publication dateVTAug 24, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Marlborough, MA, US
71/73Previous applicant/ownerINHFSumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Cambridge, MA, US
Date of update of the procedureREGTAug 24, 2023